Companies Dominating the Epilepsy Monitoring Devices Landscape
- Natus Medical Incorporated
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Compumedics Limited
- Empatica Inc.
- Magstim, Inc.
- Nihon Kohden Corporation
- Medtronic Plc
- Boston Scientific Corporation
- Masimo Corporation
- Drägerwerk AG & Co. KGaA
- Abbott Laboratories
Browse Key Market Insights with Data Illustration:
In the News
-
Empatica Inc. has obtained Food and Drug Administration (FDA) approval for Embrace2, which employs AI (advanced machine learning) in a wristwatch. It uses Electrodermal Activity (EDA), a signal that stress researchers employ to measure physiological changes associated with sympathetic nervous system activity.
-
Magstim, Inc. developed ‘Horizon 3.0’, which has received clearance from the FDA (Food and Drug Administration) as a transcranial magnetic stimulation platform. It offers improved workflows with guided transcranial magnetic stimulation (TMS), and analytics for the therapeutic context.
